India Vaccine Approval
- All
- News
- Videos
-
New Oral Polio Vaccine Approved By WHO: A Boost For India's Eradication Efforts?
The World Health Organization has just prequalified an additional novel oral polio vaccine type 2 (nOPV2),a breakthrough in stopping polio outbreaks more sustainably with stronger global vaccine supply.
-
Brazil Approves World's First Single-Dose Dengue Vaccine
Brazilian authorities on Wednesday approved the world's first single-dose dengue vaccine, which they hailed as a "historic" achievement as cases of the mosquito-borne disease soar.
-
'Caution Not Anti-Science': Siddaramaiah On Covid Vaccine-Sudden Death Claim
Karnataka Chief Minister Siddaramaiah has responded to Biocon Ltd Executive Chairperson Kiran Mazumdar-Shaw's suggestion that he acknowledge the science behind vaccine development, rather than engage in retrospective blame.
-
Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology
The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.
-
Covovax Booster Dose To Be Available On CoWIN, Cost Rs 225: Report
Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute's Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday.
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
India's Intranasal Covid Vaccine Is Here. Can Be Availed On COWIN Platform
Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above and is likely to be introduced on the Co-WIN platform Friday evening, official sources said.
-
Nasal Vaccine Available From Today. Where You Can Get It
The government today approved the inclusion of an intranasal Covid vaccine in the vaccination programme as a booster dose for adults. The inclusion comes amid a surge in cases in China and some other countries.
-
Hyderabad-Based Biological E Gets Approval For Pneumococcal Conjugate Vaccine
Hyderabad-based pharmaceutical and vaccine manufacturer Biological E Limited (BE), on Friday announced that its 14-valent paediatric Pneumococcal Conjugate Vaccine has received approval for manufacture and commercialisation in India.
-
New Oral Polio Vaccine Approved By WHO: A Boost For India's Eradication Efforts?
The World Health Organization has just prequalified an additional novel oral polio vaccine type 2 (nOPV2),a breakthrough in stopping polio outbreaks more sustainably with stronger global vaccine supply.
-
Brazil Approves World's First Single-Dose Dengue Vaccine
Brazilian authorities on Wednesday approved the world's first single-dose dengue vaccine, which they hailed as a "historic" achievement as cases of the mosquito-borne disease soar.
-
'Caution Not Anti-Science': Siddaramaiah On Covid Vaccine-Sudden Death Claim
Karnataka Chief Minister Siddaramaiah has responded to Biocon Ltd Executive Chairperson Kiran Mazumdar-Shaw's suggestion that he acknowledge the science behind vaccine development, rather than engage in retrospective blame.
-
Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology
The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.
-
Covovax Booster Dose To Be Available On CoWIN, Cost Rs 225: Report
Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute's Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday.
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
India's Intranasal Covid Vaccine Is Here. Can Be Availed On COWIN Platform
Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above and is likely to be introduced on the Co-WIN platform Friday evening, official sources said.
-
Nasal Vaccine Available From Today. Where You Can Get It
The government today approved the inclusion of an intranasal Covid vaccine in the vaccination programme as a booster dose for adults. The inclusion comes amid a surge in cases in China and some other countries.
-
Hyderabad-Based Biological E Gets Approval For Pneumococcal Conjugate Vaccine
Hyderabad-based pharmaceutical and vaccine manufacturer Biological E Limited (BE), on Friday announced that its 14-valent paediatric Pneumococcal Conjugate Vaccine has received approval for manufacture and commercialisation in India.
